Selected research
Market Analysis & Forecast
Global Synthetic Biology Automation Platform Market Analysis and Forecast 2026-2032
Market perspective
The global Synthetic Biology Automation Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Synthetic Biology Automation Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Synthetic Biology Automation Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Synthetic Biology Automation Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Synthetic Biology Automation Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Synthetic Biology Automation Platform include Ginkgo Bioworks, Amyris, Codexis, Ningbo Enzyme, Enhe Bio, Strateos, Asimov, Lattice Automation and HighRes Biosolutions, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Synthetic Biology Automation Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Synthetic Biology Automation Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for Synthetic Biology Automation Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Synthetic Biology Automation Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Synthetic Biology Automation Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Synthetic Biology Automation Platform revenue, projected growth trends, production technology, application and end-user industry.
Synthetic Biology Automation Platform Segment by Company
Ginkgo Bioworks
Amyris
Codexis
Ningbo Enzyme
Enhe Bio
Strateos
Asimov
Lattice Automation
HighRes Biosolutions
Integrated DNA Technologies (IDT)
Tidetron Bio
Synthetic Biology Automation Platform Segment by Type
small Production
Mass Production
Synthetic Biology Automation Platform Segment by Application
Chemicals
Pharmaceuticals
Food
Others
Synthetic Biology Automation Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synthetic Biology Automation Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Synthetic Biology Automation Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synthetic Biology Automation Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Synthetic Biology Automation Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Synthetic Biology Automation Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Synthetic Biology Automation Platform revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- small Production
- Mass Production
Applications
- Chemicals
- Pharmaceuticals
- Food
- Others
Companies covered
- Ginkgo Bioworks
- Amyris
- Codexis
- Ningbo Enzyme
- Enhe Bio
- Strateos
- Asimov
- Lattice Automation
- HighRes Biosolutions
- Integrated DNA Technologies (IDT)
- Tidetron Bio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Synthetic Biology Automation Platform Market by Type
- 1.2.1 Global Synthetic Biology Automation Platform Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 small Production
- 1.2.3 Mass Production
- 1.3 Synthetic Biology Automation Platform Market by Application
- 1.3.1 Global Synthetic Biology Automation Platform Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Chemicals
- 1.3.3 Pharmaceuticals
- 1.3.4 Food
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Synthetic Biology Automation Platform Market Dynamics
- 2.1 Synthetic Biology Automation Platform Industry Trends
- 2.2 Synthetic Biology Automation Platform Industry Drivers
- 2.3 Synthetic Biology Automation Platform Industry Opportunities and Challenges
- 2.4 Synthetic Biology Automation Platform Industry Restraints
3 Global Growth Perspective
- 3.1 Global Synthetic Biology Automation Platform Market Perspective (2021-2032)
- 3.2 Global Synthetic Biology Automation Platform Growth Trends by Region
- 3.2.1 Global Synthetic Biology Automation Platform Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Synthetic Biology Automation Platform Market Size by Region (2021-2026)
- 3.2.3 Global Synthetic Biology Automation Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Synthetic Biology Automation Platform Revenue by Players
- 4.1.1 Global Synthetic Biology Automation Platform Revenue by Players (2021-2026)
- 4.1.2 Global Synthetic Biology Automation Platform Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Synthetic Biology Automation Platform Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Synthetic Biology Automation Platform Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Synthetic Biology Automation Platform Key Players Headquarters & Area Served
- 4.4 Global Synthetic Biology Automation Platform Players, Product Type & Application
- 4.5 Global Synthetic Biology Automation Platform Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Synthetic Biology Automation Platform Market CR5 and HHI
- 4.6.3 2025 Synthetic Biology Automation Platform Tier 1, Tier 2, and Tier 3
5 Synthetic Biology Automation Platform Market Size by Type
- 5.1 Global Synthetic Biology Automation Platform Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Synthetic Biology Automation Platform Revenue by Type (2021-2032)
- 5.3 Global Synthetic Biology Automation Platform Revenue Market Share by Type (2021-2032)
6 Synthetic Biology Automation Platform Market Size by Application
- 6.1 Global Synthetic Biology Automation Platform Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Synthetic Biology Automation Platform Revenue by Application (2021-2032)
- 6.3 Global Synthetic Biology Automation Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Ginkgo Bioworks
- 7.1.1 Ginkgo Bioworks Company Information
- 7.1.2 Ginkgo Bioworks Business Overview
- 7.1.3 Ginkgo Bioworks Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 7.1.4 Ginkgo Bioworks Synthetic Biology Automation Platform Product Portfolio
- 7.1.5 Ginkgo Bioworks Recent Developments
- 7.2 Amyris
- 7.2.1 Amyris Company Information
- 7.2.2 Amyris Business Overview
- 7.2.3 Amyris Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 7.2.4 Amyris Synthetic Biology Automation Platform Product Portfolio
- 7.2.5 Amyris Recent Developments
- 7.3 Codexis
- 7.3.1 Codexis Company Information
- 7.3.2 Codexis Business Overview
- 7.3.3 Codexis Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 7.3.4 Codexis Synthetic Biology Automation Platform Product Portfolio
- 7.3.5 Codexis Recent Developments
- 7.4 Ningbo Enzyme
- 7.4.1 Ningbo Enzyme Company Information
- 7.4.2 Ningbo Enzyme Business Overview
- 7.4.3 Ningbo Enzyme Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 7.4.4 Ningbo Enzyme Synthetic Biology Automation Platform Product Portfolio
- 7.4.5 Ningbo Enzyme Recent Developments
- 7.5 Enhe Bio
- 7.5.1 Enhe Bio Company Information
- 7.5.2 Enhe Bio Business Overview
- 7.5.3 Enhe Bio Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 7.5.4 Enhe Bio Synthetic Biology Automation Platform Product Portfolio
- 7.5.5 Enhe Bio Recent Developments
- 7.6 Strateos
- 7.6.1 Strateos Company Information
- 7.6.2 Strateos Business Overview
- 7.6.3 Strateos Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 7.6.4 Strateos Synthetic Biology Automation Platform Product Portfolio
- 7.6.5 Strateos Recent Developments
- 7.7 Asimov
- 7.7.1 Asimov Company Information
- 7.7.2 Asimov Business Overview
- 7.7.3 Asimov Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 7.7.4 Asimov Synthetic Biology Automation Platform Product Portfolio
- 7.7.5 Asimov Recent Developments
- 7.8 Lattice Automation
- 7.8.1 Lattice Automation Company Information
- 7.8.2 Lattice Automation Business Overview
- 7.8.3 Lattice Automation Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 7.8.4 Lattice Automation Synthetic Biology Automation Platform Product Portfolio
- 7.8.5 Lattice Automation Recent Developments
- 7.9 HighRes Biosolutions
- 7.9.1 HighRes Biosolutions Company Information
- 7.9.2 HighRes Biosolutions Business Overview
- 7.9.3 HighRes Biosolutions Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 7.9.4 HighRes Biosolutions Synthetic Biology Automation Platform Product Portfolio
- 7.9.5 HighRes Biosolutions Recent Developments
- 7.10 Integrated DNA Technologies (IDT)
- 7.10.1 Integrated DNA Technologies (IDT) Company Information
- 7.10.2 Integrated DNA Technologies (IDT) Business Overview
- 7.10.3 Integrated DNA Technologies (IDT) Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 7.10.4 Integrated DNA Technologies (IDT) Synthetic Biology Automation Platform Product Portfolio
- 7.10.5 Integrated DNA Technologies (IDT) Recent Developments
- 7.11 Tidetron Bio
- 7.11.1 Tidetron Bio Company Information
- 7.11.2 Tidetron Bio Business Overview
- 7.11.3 Tidetron Bio Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 7.11.4 Tidetron Bio Synthetic Biology Automation Platform Product Portfolio
- 7.11.5 Tidetron Bio Recent Developments
8 North America
- 8.1 North America Synthetic Biology Automation Platform Revenue (2021-2032)
- 8.2 North America Synthetic Biology Automation Platform Revenue by Type (2021-2032)
- 8.2.1 North America Synthetic Biology Automation Platform Revenue by Type (2021-2026)
- 8.2.2 North America Synthetic Biology Automation Platform Revenue by Type (2027-2032)
- 8.3 North America Synthetic Biology Automation Platform Revenue Share by Type (2021-2032)
- 8.4 North America Synthetic Biology Automation Platform Revenue by Application (2021-2032)
- 8.4.1 North America Synthetic Biology Automation Platform Revenue by Application (2021-2026)
- 8.4.2 North America Synthetic Biology Automation Platform Revenue by Application (2027-2032)
- 8.5 North America Synthetic Biology Automation Platform Revenue Share by Application (2021-2032)
- 8.6 North America Synthetic Biology Automation Platform Revenue by Country
- 8.6.1 North America Synthetic Biology Automation Platform Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Synthetic Biology Automation Platform Revenue by Country (2021-2026)
- 8.6.3 North America Synthetic Biology Automation Platform Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Synthetic Biology Automation Platform Revenue (2021-2032)
- 9.2 Europe Synthetic Biology Automation Platform Revenue by Type (2021-2032)
- 9.2.1 Europe Synthetic Biology Automation Platform Revenue by Type (2021-2026)
- 9.2.2 Europe Synthetic Biology Automation Platform Revenue by Type (2027-2032)
- 9.3 Europe Synthetic Biology Automation Platform Revenue Share by Type (2021-2032)
- 9.4 Europe Synthetic Biology Automation Platform Revenue by Application (2021-2032)
- 9.4.1 Europe Synthetic Biology Automation Platform Revenue by Application (2021-2026)
- 9.4.2 Europe Synthetic Biology Automation Platform Revenue by Application (2027-2032)
- 9.5 Europe Synthetic Biology Automation Platform Revenue Share by Application (2021-2032)
- 9.6 Europe Synthetic Biology Automation Platform Revenue by Country
- 9.6.1 Europe Synthetic Biology Automation Platform Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Synthetic Biology Automation Platform Revenue by Country (2021-2026)
- 9.6.3 Europe Synthetic Biology Automation Platform Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Synthetic Biology Automation Platform Revenue (2021-2032)
- 10.2 China Synthetic Biology Automation Platform Revenue by Type (2021-2032)
- 10.2.1 China Synthetic Biology Automation Platform Revenue by Type (2021-2026)
- 10.2.2 China Synthetic Biology Automation Platform Revenue by Type (2027-2032)
- 10.3 China Synthetic Biology Automation Platform Revenue Share by Type (2021-2032)
- 10.4 China Synthetic Biology Automation Platform Revenue by Application (2021-2032)
- 10.4.1 China Synthetic Biology Automation Platform Revenue by Application (2021-2026)
- 10.4.2 China Synthetic Biology Automation Platform Revenue by Application (2027-2032)
- 10.5 China Synthetic Biology Automation Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Synthetic Biology Automation Platform Revenue (2021-2032)
- 11.2 Asia Synthetic Biology Automation Platform Revenue by Type (2021-2032)
- 11.2.1 Asia Synthetic Biology Automation Platform Revenue by Type (2021-2026)
- 11.2.2 Asia Synthetic Biology Automation Platform Revenue by Type (2027-2032)
- 11.3 Asia Synthetic Biology Automation Platform Revenue Share by Type (2021-2032)
- 11.4 Asia Synthetic Biology Automation Platform Revenue by Application (2021-2032)
- 11.4.1 Asia Synthetic Biology Automation Platform Revenue by Application (2021-2026)
- 11.4.2 Asia Synthetic Biology Automation Platform Revenue by Application (2027-2032)
- 11.5 Asia Synthetic Biology Automation Platform Revenue Share by Application (2021-2032)
- 11.6 Asia Synthetic Biology Automation Platform Revenue by Country
- 11.6.1 Asia Synthetic Biology Automation Platform Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Synthetic Biology Automation Platform Revenue by Country (2021-2026)
- 11.6.3 Asia Synthetic Biology Automation Platform Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Synthetic Biology Automation Platform Revenue (2021-2032)
- 12.2 SAMEA Synthetic Biology Automation Platform Revenue by Type (2021-2032)
- 12.2.1 SAMEA Synthetic Biology Automation Platform Revenue by Type (2021-2026)
- 12.2.2 SAMEA Synthetic Biology Automation Platform Revenue by Type (2027-2032)
- 12.3 SAMEA Synthetic Biology Automation Platform Revenue Share by Type (2021-2032)
- 12.4 SAMEA Synthetic Biology Automation Platform Revenue by Application (2021-2032)
- 12.4.1 SAMEA Synthetic Biology Automation Platform Revenue by Application (2021-2026)
- 12.4.2 SAMEA Synthetic Biology Automation Platform Revenue by Application (2027-2032)
- 12.5 SAMEA Synthetic Biology Automation Platform Revenue Share by Application (2021-2032)
- 12.6 SAMEA Synthetic Biology Automation Platform Revenue by Country
- 12.6.1 SAMEA Synthetic Biology Automation Platform Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Synthetic Biology Automation Platform Revenue by Country (2021-2026)
- 12.6.3 SAMEA Synthetic Biology Automation Platform Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst